Zydus inks licensing agreement with Daewoong Pharmaceutical for leuprolide injectable in the US
The exclusive agreement also includes development, regulatory, and commercialization milestone payments based on the successful outcome
The exclusive agreement also includes development, regulatory, and commercialization milestone payments based on the successful outcome
Methylene blue is a cationic thiazine dye that necessitates specialised capabilities and expertise to develop and manufacture the product
Ivabradine Tablets, 5 mg and 7.5 mg had annual sales of USD 136.5 mn in the United States
The agreement demonstrates a shared commitment to advance precision medicine and improve patient outcomes in the region
Zydus will pay an upfront consideration of GBP 68 million and yearly earn-outs until 2026
The drug will be marketed by Sun Pharma under the brand name RYTSTAT
Punit has more than 20 years of experience in the generics and branded pharmaceutical marketplace
Sugammadex Injection is indicated for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide
Aim is to treat Dyslipidemia by inhibiting PCSK9 with a novel entity
Clindamycin Phosphate Gel is used to treat acne
Subscribe To Our Newsletter & Stay Updated